Legence's 15min chart shows Bollinger Bands Narrowing and KDJ Death Cross.
PorAinvest
jueves, 2 de octubre de 2025, 2:36 pm ET1 min de lectura
LGN--
Financial Performance
NeueHealth reported strong financial results in the second quarter of 2025, marking its sixth consecutive quarter of Adjusted EBITDA profitability. The company served approximately 694,000 consumers, representing a 45% increase from the previous year . Key financial metrics for Q2 2025 include revenue of $209.1 million, net income from continuing operations of $6.8 million, and Adjusted EBITDA of $19.0 million .
The company's value-based consumers increased to 546,000, up from 364,000 in the previous year, while enablement services lives grew to 148,000 from 113,000 . NeueHealth continues to advance its end-to-end, value-based care enablement platform across ACA Marketplace, Medicare, and Medicaid product categories .
Market Indicators
According to the 15-minute chart provided by Legence, the Bollinger Bands are narrowing, and a KDJ Death Cross occurred on October 2, 2025, at 14:30. This suggests that the magnitude of stock price fluctuations is decreasing and that the momentum of the stock price is shifting towards the downside, with a potential for further decreases .
Recent Developments
NeueHealth has completed its previously announced take-private merger with New Enterprise Associates (NEA) in a transaction valued at approximately $1.465 billion. Common stockholders will receive $7.33 per share in cash, while certain stockholders, including NEA and 12 existing investors, have opted to roll over their shares into the private entity [1]. Following the transaction, NeueHealth's common stock ceased trading on the NYSE on October 2, 2025, and the company will terminate its SEC reporting obligations [1].
Conclusion
NeueHealth's recent financial performance and market indicators provide a mixed picture for investors. While the company continues to show strong financial results, the narrowing Bollinger Bands and KDJ Death Cross suggest a potential downward trend in the stock price. Investors should closely monitor these indicators and the company's future earnings reports to make informed investment decisions.
References
[1] https://www.stocktitan.net/news/NEUE/
https://www.stocktitan.net/news/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NE
NEUE--
According to the 15-minute chart provided by Legence, the Bollinger Bands are narrowing, and a KDJ Death Cross occurred on October 2, 2025 at 14:30. This suggests that the magnitude of stock price fluctuations is decreasing and that the momentum of the stock price is shifting towards the downside, with a potential for further decreases.
NeueHealth Inc. (NEUE), a technology-enabled healthcare solutions provider, has been making significant strides in the healthcare industry. The company's recent financial performance and market indicators provide valuable insights for investors and healthcare professionals.Financial Performance
NeueHealth reported strong financial results in the second quarter of 2025, marking its sixth consecutive quarter of Adjusted EBITDA profitability. The company served approximately 694,000 consumers, representing a 45% increase from the previous year . Key financial metrics for Q2 2025 include revenue of $209.1 million, net income from continuing operations of $6.8 million, and Adjusted EBITDA of $19.0 million .
The company's value-based consumers increased to 546,000, up from 364,000 in the previous year, while enablement services lives grew to 148,000 from 113,000 . NeueHealth continues to advance its end-to-end, value-based care enablement platform across ACA Marketplace, Medicare, and Medicaid product categories .
Market Indicators
According to the 15-minute chart provided by Legence, the Bollinger Bands are narrowing, and a KDJ Death Cross occurred on October 2, 2025, at 14:30. This suggests that the magnitude of stock price fluctuations is decreasing and that the momentum of the stock price is shifting towards the downside, with a potential for further decreases .
Recent Developments
NeueHealth has completed its previously announced take-private merger with New Enterprise Associates (NEA) in a transaction valued at approximately $1.465 billion. Common stockholders will receive $7.33 per share in cash, while certain stockholders, including NEA and 12 existing investors, have opted to roll over their shares into the private entity [1]. Following the transaction, NeueHealth's common stock ceased trading on the NYSE on October 2, 2025, and the company will terminate its SEC reporting obligations [1].
Conclusion
NeueHealth's recent financial performance and market indicators provide a mixed picture for investors. While the company continues to show strong financial results, the narrowing Bollinger Bands and KDJ Death Cross suggest a potential downward trend in the stock price. Investors should closely monitor these indicators and the company's future earnings reports to make informed investment decisions.
References
[1] https://www.stocktitan.net/news/NEUE/
https://www.stocktitan.net/news/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NE
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios